Alexander Krujatz

Alexander holds a Master’s degree from Leipzig Graduate School of Management (HHL) in Leipzig, Germany.

Having begun his career in management consulting, Alexander moved to diverse commercial and managerial assignments in key geographies of Novartis’ Sandoz division. Most recently, he was the Managing Director of Alcon (Nordic region), the largest eye care device company in the world, where he focused on turnaround and commercial execution.

He has since joined Centrient Pharmaceuticals in December of 2021 as Chief Commercial Officer Finished Dosage Forms (FDF).